Barclays Cuts HCA Healthcare (NYSE:HCA) Price Target to $402.00

HCA Healthcare (NYSE:HCA) had its target price decreased by Barclays from $427.00 to $402.00 in a report released on Thursday morning, Marketbeat.com reports. Barclays currently has an equal weight rating on the stock.

A number of other equities research analysts have also recently issued reports on the stock. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. TD Cowen lowered their price objective on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Leerink Partners decreased their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Truist Financial set a $413.00 price objective on HCA Healthcare in a research note on Thursday, June 4th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Fourteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $486.14.

HCA Healthcare Price Performance

NYSE:HCA opened at $371.60 on Thursday. HCA Healthcare has a 1-year low of $330.00 and a 1-year high of $556.52. The firm has a market capitalization of $82.44 billion, a P/E ratio of 12.78, a PEG ratio of 1.23 and a beta of 1.12. The company’s fifty day moving average price is $392.25 and its 200-day moving average price is $457.05.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the previous year, the business posted $6.45 EPS. The business’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts anticipate that HCA Healthcare will post 29.73 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in HCA. Brighton Jones LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC boosted its stake in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC raised its stake in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the period. Jump Financial LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $2,073,000. Finally, Sei Investments Co. raised its position in HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.